GM5: Food and Drug Administration - Elizabeth Mansfield
Virginia Keys, US Food and Drug Administration
GM5: European Science Foundation's Personalized Medicine Launch Event- Dan Roden
GM5: PGRN Programs Related to Genomic Medicine Implementation - Dan Roden
GM5: Welcome, Introductions - Rex Chisholm
Dx2010: Markers to Market: Elizabeth Mansfield, FDA
11/10/2014 - Session 2A - Evolving paradigm for Companion Diagnostics
Registrar Corp: Assistance with U.S. Food and Drug Administration (French)
Hearing: FY 2019 Budget - Food and Drug Administration (EventID=108145)
FDA Food Canning Establishment (FCE) and Process Filing (SID) Regulations
GM5: CAP Genomic Medicine Policy Framework: Clinical Issues - Debra Leonard
Friends of Cancer Research Annual Meeting Day 2
Our Exclusive Interview with Thomas Abrams at the FDA Hearings
E04.2 From pharmacogenomics testing to point-of-care clinical decision support
Jerry Yeo (University of Chicago) previews presentation for Personalized Diagnostics Today
Registrar Corp: Assistance with U.S. Food and Drug Administration (Español)
Strategies to reduce drug costs
Interventional pharmoeconomics to reduce the cost of therapy
GM4: Preliminary Action Items Related to Professional Societies - Marc Williams
GM2: Family History in Primary Care - Geoff Ginsburg
